News

Ophthalmology Times1d
Survey data shows trends for AMD and DME treatments and future prospects
The survey shows the evolving landscape of nAMD and DME treatments, highlighting physician preferences, payer influences, and ...
Biologic Competition, Payer Pressures, And Gene Therapy Momentum Define A Pivotal Moment In Namd And DME Management, According To Spherix Global Insights
More than 70% of surveyed U.S. ophthalmologists anticipate a fundamentally transformed approach to managing nAMD and DME within the next five years.< ...
The Bakersfield Californian6d
Biologic Competition, Payer Pressures, and Gene Therapy Momentum Define a Pivotal Moment in ...
Recently released research from Spherix Global Insights provides a timely look at the increasingly competitive and complex treatment landscape for neovascular age-related ...